Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.
Publication
, Journal Article
Narayanaswami, P; Sanders, DB
Published in: Lancet Neurol
August 2024
Duke Scholars
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
August 2024
Volume
23
Issue
8
Start / End Page
762 / 763
Location
England
Related Subject Headings
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Immunosuppressive Agents
- Humans
- Azathioprine
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Narayanaswami, P., & Sanders, D. B. (2024). Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply. Lancet Neurol, 23(8), 762–763. https://doi.org/10.1016/S1474-4422(24)00234-5
Narayanaswami, Pushpa, and Donald B. Sanders. “Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.” Lancet Neurol 23, no. 8 (August 2024): 762–63. https://doi.org/10.1016/S1474-4422(24)00234-5.
Narayanaswami P, Sanders DB. Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply. Lancet Neurol. 2024 Aug;23(8):762–3.
Narayanaswami, Pushpa, and Donald B. Sanders. “Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply.” Lancet Neurol, vol. 23, no. 8, Aug. 2024, pp. 762–63. Pubmed, doi:10.1016/S1474-4422(24)00234-5.
Narayanaswami P, Sanders DB. Azathioprine and mycophenolate mofetil in myasthenia gravis - Authors' reply. Lancet Neurol. 2024 Aug;23(8):762–763.
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
August 2024
Volume
23
Issue
8
Start / End Page
762 / 763
Location
England
Related Subject Headings
- Neurology & Neurosurgery
- Mycophenolic Acid
- Myasthenia Gravis
- Immunosuppressive Agents
- Humans
- Azathioprine
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences